Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

NCT00719849 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped A new protocol was developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
PROCEDURE: umbilical cord blood transplantation
RADIATION: total body irradiation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]